Items where Author is "Gorog, Diana A."

Item Type No Grouping

Article

Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor. (2024) Seung-Yul Lee, Jae Young Cho, Diana A. Gorog, Dominick J. Angiolillo, Kyeong Ho Yun, Jong-Hwa Ahn, Jin-Sin Koh, Yongwhi Park, Seok-Jae Hwang, Jin-Yong Hwang, Jin Won Kim, Yangsoo Jang and Young-Hoon Jeong

Is There Long-Term Clinical Equipoise Between CABG and PCI for Isolated Left Anterior Descending Artery Disease? (2023) Eliano P. Navarese, Eleonora Ruscio and Diana A. Gorog

Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support A Practical Approach. (2023) Charlotte J. Van Edom, Mario Gramegna, Luca Baldetti, Alessandro Beneduce, Thomas Castelein, Dieter Dauwe, Pascal Frederiks, Gennaro Giustino, Marc Jacquemin, Stefan P. Janssens, Vasileios F. Panoulas, Janine Pöss, Alexander Rosenberg, Hannah A.I. Schaubroeck, Benedikt Schrage, Guido Tavazzi, Thomas Vanassche, Leen Vercaemst, Dirk Vlasselaers, Pascal Vranckx, Jan Belohlavek, Diana A. Gorog, Kurt Huber, Alexandre Mebazaa, Bart Meyns, Federico Pappalardo, Anna M. Scandroglio, Gregg W. Stone, Dirk Westermann, Alaide Chieffo, Susanna Price and Christophe Vandenbriele

PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection. (2023) Eliano P. Navarese, Przemysław Podhajski, Paul A. Gurbel, Klaudyna Grzelakowska, Eleonora Ruscio, Udaya Tantry, Przemysław Magielski, Aldona Kubica, Piotr Niezgoda, Piotr Adamski, Roman Junik, Grzegorz Przybylski, Marta Pilaczyńska-Cemel, Manali Rupji, Giuseppe Specchia, Jarosław Pinkas, Robert Gajda, Diana A. Gorog, Felicita Andreotti and Jacek Kubica

Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction. (2022) Rahim Kanji, Ying X. Gue, Mohamed F. Farag, Neil H. Spencer, Nicola J. Mutch and Diana A. Gorog

Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients? (2022) Ying X. Gue, Diana A. Gorog and Gregory Y.H. Lip

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. (2022) Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, Udaya S. Tantry, Jeffrey S. Berger, Mark Y. Chan, Daniel Duerschmied, Susan S. Smyth, William A.E. Parker, Ramzi A. Ajjan, Gemma Vilahur, Lina Badimon, Jurrien M.ten Berg, Hugo ten Cate, Flora Peyvandi, Taia T. Wang and Richard C. Becker

Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock JACC Review Topic of the Week. (2022) Christophe Vandenbriele, Deepa J. Arachchillage, Pascal Frederiks, Gennaro Giustino, Diana A. Gorog, Mario Gramegna, Stefan Janssens, Bart Meyns, Amin Polzin, Mara Scandroglio, Benedikt Schrage, Gregg W. Stone, Guido Tavazzi, Thomas Vanassche, Pascal Vranckx, Dirk Westermann, Susanna Price and Alaide Chieffo

Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. (2021) Jacek Kubica, Piotr Adamski, Diana A. Gorog, Aldona Kubica, Bernd Jilma, Andrzej Budaj, Jolanta M. Siller-Matula, Paul A. Gurbel, Dimitrios Alexopoulos, Jolita Badarienė, Paweł Dąbrowski, Dariusz Dudek, Evangelos Giannitsis, Grzegorz Horszczaruk, Miłosz J. Jaguszewski, Stefan James, Young Hoon Jeong, Michał Kryjak, Piotr Niezgoda, Małgorzata Ostrowska, Giuseppe Patti, Janusz Romanek, Salvatore Di Somma, Giuseppe Specchia, Udaya Tantry, Mariusz Gąsior, Agnieszka Tycińska, Wojciech Wojakowski, Katarzyna Buszko, Robert Gil, Marcin Gruchała, Jarosław Kasprzak, Andrzej Kleinrok, Jacek Legutko, Maciej Lesiak and Eliano P. Navarese

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study. (2021) Jacek Kubica, Piotr Adamski, Piotr Niezgoda, Aldona Kubica, Przemysław Podhajski, Malwina Barańska, Julia M. Umińska, Łukasz Pietrzykowski, Małgorzata Ostrowska, Jolanta M. Siller-Matula, Jolita Badarienė, Stanisław Bartuś, Andrzej Budaj, Sławomir Dobrzycki, Łukasz Fidor, Mariusz Gąsior, Jacek Gessek, Marek Gierlotka, Robert Gil, Jarosław Gorący, Paweł Grzelakowski, Tomasz Hajdukiewicz, Miłosz Jaguszewski, Marianna Janion, Jarosław Kasprzak, Adam Kern, Artur Klecha, Andrzej Kleinrok, Wacław Kochman, Bartosz Krakowiak, Jacek Legutko, Maciej Lesiak, Marcin Nosal, Grzegorz Piotrowski, Andrzej Przybylski, Tomasz Roleder, Grzegorz Skonieczny, Grzegorz Sobieszek, Agnieszka Tycińska, Dariusz Wojciechowski, Wojciech Wojakowski, Jarosław Wójcik, Marzenna Zielińska, Aleksander Żurakowski, Giuseppe Specchia, Diana A. Gorog and Eliano P. Navarese

Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. (2020) Ying X. Gue, Maria Tennyson, Jovia Gao, Shuhui Ren, Rahim Kanji and Diana A. Gorog

Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes. (2020) Robert F. Storey, Paul A. Gurbel, Jurrien ten Berg, Corine Bernaud, George D. Dangas, Jean Marie Frenoux, Diana A. Gorog, Abdel Hmissi, Vijay Kunadian, Stefan K. James, Jean Francois Tanguay, Henry Tran, Dietmar Trenk, Mike Ufer, Pim van der Harst, Arnoud W.J. Van't Hof and Dominick J. Angiolillo

Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a) : Findings from a randomized controlled cross-over trial. (2019) Tina Z. Khan, Diana A. Gorog, Deepa J. Arachchillage, Josefin Ahnström, Samantha Rhodes, Jacqueline Donovan, Winston Banya, Alison Pottle, Mahmoud Barbir and Dudley J. Pennell

A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome. (2019) Ying X. Gue, Sanjay Prasad, David Isenberg and Diana A. Gorog

Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events : the RISK PPCI study. (2019) Mohamed Farag, Nikolaos Spinthakis, Ying X. Gue, Manivannan Srinivasan, Keith Sullivan, David Wellsted and Diana A. Gorog

A rare cause of myocardial infarction with non-obstructive coronary arteries-case report of ST-segment elevation myocardial infarction caused by a mediastinal mass. (2018) Ying X. Gue, Majid Anwar and Diana A. Gorog

Other

Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review. (2022) Mohamed Farag, Visvesh Jeyalan, Jose Luis Ferreiro, Young-Hoon Jeong, Tobias Geisler and Diana A. Gorog

The East Asian Paradox : An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. (2020) Hyun Kuk Kim, Udaya S. Tantry, Sidney C. Smith, Myung Ho Jeong, Seung Jung Park, Moo Hyun Kim, Do Sun Lim, Eun Seok Shin, Duk Woo Park, Yong Huo, Shao Liang Chen, Zheng Bo, Shinya Goto, Takeshi Kimura, Satoshi Yasuda, Wen Jone Chen, Mark Chan, Daniel Aradi, Tobias Geisler, Diana A. Gorog, Dirk Sibbing, Gregory Y.H. Lip, Dominick J. Angiolillo, Paul A. Gurbel and Young Hoon Jeong

Aspirin related platelet reactivity as a determinant of ten year survival in high risk non-ST segment elevation myocardial infarction (NSTEMI) patients. (2020) Nazish Khan, Mamas A. Mamas, Alexandra Moss, Diana A. Gorog, Peter Nightingale, Angel Armesilla, Andrew Smallwood, Shahzad Munir, Saib Khogali, Ben Wrigley and James M. Cotton

Low-grade endotoxaemia and platelets : A deadly aggregation. (2020) Luca Liberale and Diana A. Gorog

Importance of endogenous fibrinolysis in platelet thrombus formation. (2017) Ying X. Gue and Diana A. Gorog